Summary Numerous methods have been proposed for the detection of hypoxic cells using nitroimidazoles labelled with both radioactive and stable isotopes where the isotopic label becomes bound as a result of reductive metabolism of the nitro group. A new probe for hypoxia, 7-(4'-(2-nitroimidazol-1-yl)-butyl)-theophylline, is described where an immunologically recognisable hapten (theophylline) is covalently linked to a 2-nitroimidazole. Bioreduction of the nitroimidazole leads to binding of bioreductive metabolites, and hence the theophylline side-chain, to intracellular molecules. Immunochemical procedures are then used to stain cells containing the bound theophylline using an FITC-conjugated anti-serum. Flow cytometric analysis of stained cells is facilitated by co-staining cellular DNA, which allows discrimination of single cells in the sample and rejection of cell clumps and debris. The alternative use of an immunoperoxidase-conjugated anti-serum has been used to demonstrate the localisation of hypoxic cells in frozen tumour sections.
The existence of poorly oxygenated radioresistant cells in tumours is thought to be one of the factors contributing to local failure of radiotherapy and tumour regrowth (Gray et al., 1953; Churchill-Davidson et al., 1966; Bush et al., 1978; Mueller-Klieser et al., 1981; Dische, 1985; Dische et al., 1986; Overgaard et al., 1986) . A simple, rapid clinical test for the presence of hypoxic cells in tumours could enable radiotherapy to be optimised for individual patients on the basis of the oxygen status of their tumours. Adjuncts to radiotherapy such as hypoxic cell sensitisers and hyperbaric or normobaric oxygen could then be administered to those patients most likely to benefit from them.
Of the methods that have been proposed for determining the hypoxic fractions of tumours, several are based on the hypoxia-dependent bioreductive metabolism of a labelled 2-nitroimidazole which results in binding of labelled fragments of the original compound to cellular macromolecules. Various labels have been proposed, including 3H (Raleigh et al., 1985) , 14C (Chapman et al., 1981; Franko & Chapman, 1982; Garrecht & Chapman, 1983) , 75Br, 76Br, 7Br (Rasey et al., 1985) and '9F : 3H-misonidazole has been administered to small numbers of patients with treatment-resistant tumours (Urtasun et al., 1986) . Identification of hypoxic cells using radiolabelling requires prolonged autoradiography to detect labelled regions of tumour sections. NMR detection of bioreductively bound metabolites of fluorinated nitroimidazoles in tissues has been demonstrated experimentally and such bound metabolites have also been detected by fluorescence immunohistochemistry (Raleigh et al., 1987) .
In this paper, we describe the use of the immunologically detectable hapten theophylline, covalently bound to a 2-nitroimidazole, as a method of identifying hypoxic cells. An isotopic label on the side-chain of misonidazole binds to cellular constituents as efficiently as a ring label (Raleigh et al., 1985) and an immunologically recognised side-chain should behave similarly. Data are presented showing that this approach enables hypoxic cells to be identified both in vitro and in solid tumours in vivo.
Materials and methods

Chemicals
Synthesis of 7-(4'-(2-nitroimidazole-1-yl)-butyl)-theophylline (NITP) will be described elsewhere. Cremophor, peanut oil, Correspondence: R.J. Hodgkiss. Received 9 April 1990; and in revised form 15 August 1990. propidium iodide, RNAase and all anti-sera were obtained from Sigma Chemical Company. Dimethyl sulphoxide (DMSO) and other reagents were BDH AnalaR grade. Special gases (air + 5% C02, oxygen + 5% C02, nitrogen + 5% C02), were obtained from British Oxygen Company. Other gas mixtures containing a range of oxygen tensions were prepared by volumetric mixing of air + 5% CO2 and nitrogen + 5% CO2 into empty gas cylinders. All special gas mixtures were checked with a Thermox oxygen meter.
In vitro studies V79 379A Chinese hamster cells were maintained as exponentially growing suspension cultures in Eagle's Minimal Essential Medium with Earle's salts, modified for suspension culture, with 7.5% foetal calf serum. Cell suspensions (5 x 105 cells ml-') were stirred under air + 5% CO2 or nitrogen + 5% CO2 and incubated with drugs at 37°C as previously described (Begg et al., 1985; Hodgkiss et al., 1987) . Because of the poor water solubility of NITP it was initially dissolved at 10-50 mmol dm-3 in DMSO and small volumes added to cell suspensions in growth medium to give the appropriate dug concentration. The final concentration of DMSO was 1% or less. Following incubation with NITP cells were washed with phosphate buffered saline (PBS) and suspended in 2 ml of PBS before fixation with 20 ml 70% ethanol. Toxicity measurements were carried out under identical conditions and survival assessed in a 7-day colony forming assay.
In vivo studies (a) Tumours The carcinoma CaNT and sarcoma SaF used in this study are a moderately differentiated mammary carcinoma and an anaplastic sarcoma of spontaneous origin, respectively, which are maintained by serial passage in CBA mice. The carcinoma Rh is a moderately well differentiated adenocarcinoma of spontaneous origin which is maintained by serial passage in WH mice. Tumours were implanted as dorsal subcutaneous tumours in male mice and were used at a mean diameter of 10 mm calculated from three orthogonal measurements (b) Drug administration Administration of NITP (0.5 tLmol g9i) was by intra-peritoneal injection of the drug in peanut oil containing 10% DMSO; the total volume injected was 0.38 ml for a 35 g mouse. In the case of animals carrying Rh and SaF tumours the drug was suspended in cremophor containing 10% ethanol. Some animals were made to breathe carbogen (95% oxygen + 5% C02), following administration of the drug, by placing them in small plastic boxes (18 x 18 x 13 cm) through which carbogen was passed at I I minfollowing an initial 5 min flushing at (51 min-').
(c) Tissue preparation Animals were killed by cervical dislocation 2 h after administration of the drug, and tumours were rapidly removed and minced finely with scissors. A cell suspension was made by repeated pipetting of the fragments suspended in PBS using a 5 ml automatic pipette. The resulting suspension was filtered through 35 im nylon mesh (Lockertex, Warrington, Cheshire), centrifuged at 300g and the cell pellet resuspended in 2 ml PBS before fixation in 20 ml 70% ethanol. Once fixed in 70% ethanol, cell suspensions could be stored at 4°C for several weeks, if required, before staining.
For preparation of frozen tumour sections, freshly excised CaNT tumours were snap-frozen in liquid nitrogen. Frozen sections were cut on a cryostat at 4 lm thickness and stored at -70°C until required.
Immunochemical staining To stain for bound theophylline groups, 2 x 106 fixed cells were washed in PBS, and suspended in 1 ml PBS containing 0.5% Tween-20 and 0.1% normal goat serum for 15 min to reduce non-specific antibody binding sites; during optimisation of the staining protocol it was found that higher concentrations of goat serum reduced the specificity of binding of the antiserum. (The concentrations of first and second antibodies were also optimised for this application.) The cells were then centrifuged, resuspended in 0.25 ml polyclonal rabbit antiserum raised against theophylline and incubated for 1 h at 20C. Following this incubation, the cells were washed and resuspended in 0.5 ml PBS containing 10 l of affinityisolated goat anti-rabbit IgG FITC conjugate and incubated for I h at 20°C. The cells were then washed and suspended in 2 ml PBS for analysis. For DNA staining, cells were treated with I mg ml-' RNAase and propidium iodide (I5 pmol dm-3) added.
Before immunoperoxidase staining for bound theophylline, frozen sections were air-dried and fixed in cold acetone (4°C, 10 min'). (e) Physiology Rectal temperature measurements were carried out on control and drug-treated tumour-bearing animals using a calibrated platinum thermometer. Breathing rate measurements were also carried out on tumour-bearing animals before and after drug administration using an airtight whole body plethysmograph (Travis et al., 1979) . Relative blood flow was assessed in tumours and gastrocnemius muscle by measuring 86RbCl uptake (Sapirstein, 1958 (Figure 3a) . When cells were incubated with NITP (0.1 mmol dm 3) under a range of oxygen concentrations the value for half the hypoxic:oxic differential of metabolic binding was found to be 1,400 ppm (Figure 3b ), which is similar to the value of 3,800 ppm for half of the oxygen radiosensitising effect, determined under identical conditions (Begg et al., 1985) .
In vivo studies
Physiological measurements of tumour-bearing animals show that NITP, when injected at 0.5 timol g-I in peanut oil (Figure 4) has only a small effect on rectal temperature and little effect on breathing rate. There was also no significant effect of the drug on tumour or muscle blood flow 50 min after injection (Table I) . NITP appeared to be well tolerated and no deaths occurred in ten animals observed for 24 h following drug administration.
Bound theophylline groups could be readily detected immunochemically in mouse tumours within 45-60 min following treatment in vivo with NITP ( Figure Sa Hodgkiss and Middleton (1985) . At 0.1 mmol dm-3 NITP was not toxic in oxic or hypoxic conditions during 8 h incubation. Standard errors are smaller than the sizes of the points plotted. maximum value after 2 h. HPLC measurements of NITP in plasma show that the drug, when injected at 0.5 ltmol g-' in peanut oil, rapidly reaches a maximum plasma concentration of 100 nmol ml-' (Figure 5b ) which is sustained for a period of about I h; the plasma drug level subsequently falls with a half life of 32 min in mouse tumour and plasma. The parent drug can be detected in the tumours by HPLC before bound adducts can be detected immunologically; the delay before the appearance of bound adducts must reflect the time required for bioreductive metabolism to occur.
More bound theophylline groups were detected in cells from all tumours treated with NITP in air-breathing mice than in carbogen breathing mice (e.g. Figure 6 ). However, some high fluorescence was also observed when cells from control tumours not treated with the drug were stained for theophylline groups. This high control fluorescence resulted from two or more cells clumping together; it could be greatly reduced by staining DNA with propidium iodide and gating on the red fluorescence peak vs area signal to eliminate all particles except single cells (e.g. Figure 7 ). Single cell discrimination is achieved by this method because the width of the signal generated by a fluorescent particle in the flow cytometer is the sum of the beam width and the particle diameter. A comparison of signal area and peak separates the single cells from clumps because the increase in nuclear diameter is much greater for two or more G1 cells stuck together than occurs over the cell cycle, (Ormerod, 1989) . The diploid GI normal host cell population can be seen at about channel 15, the GI aneuploid tumour cells at channel 30 and the G2 aneuploid cells at channel 60. There may be a small contamination of the GI aneuploid cells with G2 diploid cells. Analysis of the histograms based only on single cells showed the levels of hypoxia in Table I1 ; more hypoxic cells were found in tumours from animals breathing air compared with carbogen, and less staining was observed in control animals not treated with -the drug. Work in progress suggests that similar levels of hypoxia occur in other CaNT tumours and that the reduction in tumour hypoxia observed when mice breathe carbogen correlates well with changes in the sensitivity of the tumours to fractionated radiation (Rojas et al., 1990 ). The animals with Rh and SaF tumours were injected with NITP suspended in cremophor; similar levels of staining are seen in CaNT tumours when NITP is suspended in either peanut oil or cremophor (data not shown).
Immunoperoxidase staining of frozen sections of CaNT tumours showed that bound metabolites of NITP occurred mainly at the edges of tumour cords (Figure 8 within 5-6 cell diameters of the central blood vessels, or in the necrotic material surrounding the tumour cords. Occasionally, however, a tumour cord was found in which immunoperoxidase staining occurred adjacent to the blood vessel and throughout that particular cord (Figure 8 , lower right). Such heavily stained tumour cords may represent regions that became acutely hypoxic by blood-vessel occlusion at a time when the probe had already diffused into the tumour.
Discussion
Numerous studies have demonstrated the hypoxia-specific binding of isotopically labelled 2-nitroimidazoles to cellular components and it has been possible to develop an immunohistochemical method for detecting bound metabolites of a fluorinated nitroimidazole (Raleigh et al., 1987) . We have used a commercial antiserum to theophylline to quantify similarly bound metabolites of a 2-nitroimidazole with a theophylline side-chain. In vitro studies have shown bioreductive binding of NITP to be highly hypoxia-specific and to have a similar oxygen-dependence to radiosensitivity. While there may be a small overlap between the range of intensities of fluorescent staining seen with pure oxic and hypoxic cell populations, the mean fluorescence of the two groups is well separated. Metabolic binding of NITP to hypoxic cells can be readily demonstrated under conditions where there is no toxicity. With long incubation times, a plateau is observed in the amount of bound drug detectable in cells, although the cells are still completely viable. We have observed similar binding curves with other nitro-aromatic compounds tested as fluorescent probes for hypoxic cells, under identical conditions (e.g. Begg et al., 1985) ; the apparent plateau in drug binding may reflect further metabolism of bound adducts to t100 non-recognisable forms.
The drug is tolerated well in vivo with little effect observed on body temperature, breathing rate or relative tumour and 100- (Franko, 1986) . Radiobiological studies have estimated mean hypoxic fractions of 30% (95% confidence interval 14-62%) for the Rh tumour, 38% (95% confidence interval 26-55%) for the CaNT tumour and 69% (95% confidence interval 42-100%) for the SaF tumour in animals breathing air (Moulder & Rockwell, 1984) . While similar hypoxic fractions to the radiobiological mean values are derived here from the flow cytometry data (Table II) , a direct comparison cannot be made as the estimates of radiobiological hypoxia are not contemporary and some changes in tumour growth characteristics have been noted since these estimates were made (e.g. Anderson et al., 1989 (Rojas et al., 1990) .
It has been shown that much of the bioreductive binding of misonidazole is to acid-soluble components of the cell such as glutathione (Miller et al., 1982; Smith & Born, 1984) ;
if NITP metabolites behaved similarly, fixation and permeablisation of the cells would presumably extract such low molecular weight conjugates. However, the immunochemical procedures employed here are sensitive enough to detect the remaining adducts to high molecular weight components of the cell. Although it has been reported that 90% (Miller et al., 1982) and 41% (Smith, 1984; Smith & Born, 1984) (Gray et al., 1953; Thomlinson & Gray, 1955 
